ePlus to Present at the Stifel 2017 Technology, Internet & Media Conference
May 30, 2017 12:39 pm UTC| Business
HERNDON, Va., May 30, 2017 -- ePlus inc. (NASDAQ:PLUS) today announced that it will present at 2:25 pm PT at the Stifel 2017 Technology, Internet Media Conference to be held at The Fairmont Hotel in San Francisco on...
Minerva Neurosciences to Present at Jefferies 2017 Healthcare Conference on June 6, 2017
May 30, 2017 12:38 pm UTC| Business
WALTHAM, Mass., May 30, 2017 -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system (CNS) disorders,...
Minerva Neurosciences to Present at Jefferies 2017 Healthcare Conference on June 6, 2017
May 30, 2017 12:38 pm UTC| Business
WALTHAM, Mass., May 30, 2017 -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system (CNS) disorders,...
Minerva Neurosciences to Present at Jefferies 2017 Healthcare Conference on June 6, 2017
May 30, 2017 12:38 pm UTC| Business
WALTHAM, Mass., May 30, 2017 -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system (CNS) disorders,...
Minerva Neurosciences to Present at Jefferies 2017 Healthcare Conference on June 6, 2017
May 30, 2017 12:38 pm UTC| Business
WALTHAM, Mass., May 30, 2017 -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system (CNS) disorders,...
Minerva Neurosciences to Present at Jefferies 2017 Healthcare Conference on June 6, 2017
May 30, 2017 12:38 pm UTC| Business
WALTHAM, Mass., May 30, 2017 -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system (CNS) disorders,...
Minerva Neurosciences to Present at Jefferies 2017 Healthcare Conference on June 6, 2017
May 30, 2017 12:38 pm UTC| Business
WALTHAM, Mass., May 30, 2017 -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system (CNS) disorders,...